Vantage Investment Partners LLC Has $8.13 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Vantage Investment Partners LLC trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 15,580 shares of the medical equipment provider's stock after selling 900 shares during the period. Vantage Investment Partners LLC's holdings in Intuitive Surgical were worth $8,132,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the company. AQR Capital Management LLC boosted its stake in shares of Intuitive Surgical by 12.6% during the 2nd quarter. AQR Capital Management LLC now owns 42,691 shares of the medical equipment provider's stock worth $18,958,000 after buying an additional 4,775 shares during the last quarter. Creative Planning boosted its position in Intuitive Surgical by 9.8% during the second quarter. Creative Planning now owns 63,039 shares of the medical equipment provider's stock valued at $28,043,000 after purchasing an additional 5,629 shares during the last quarter. NewEdge Advisors LLC grew its stake in Intuitive Surgical by 8.2% in the second quarter. NewEdge Advisors LLC now owns 13,825 shares of the medical equipment provider's stock valued at $6,150,000 after purchasing an additional 1,044 shares in the last quarter. Northwestern Mutual Wealth Management Co. increased its position in shares of Intuitive Surgical by 2.1% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 20,458 shares of the medical equipment provider's stock worth $9,100,000 after purchasing an additional 411 shares during the last quarter. Finally, Wellington Wealth Strategies LLC. bought a new stake in shares of Intuitive Surgical during the 2nd quarter worth approximately $241,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CEO Gary S. Guthart sold 18,151 shares of the company's stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the transaction, the chief executive officer now directly owns 24,219 shares in the company, valued at approximately $12,391,166.97. This represents a 42.84 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Jamie Samath sold 270 shares of the firm's stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,730,093.55. This trade represents a 2.99 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 42,265 shares of company stock worth $21,964,281 over the last three months. Insiders own 0.90% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on ISRG shares. Evercore ISI boosted their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday. BTIG Research boosted their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a "buy" rating in a research note on Tuesday, November 26th. Bernstein Bank raised their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a research note on Monday. Stifel Nicolaus boosted their price target on Intuitive Surgical from $525.00 to $610.00 and gave the stock a "buy" rating in a research report on Thursday, December 5th. Finally, Barclays raised their price objective on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical has an average rating of "Moderate Buy" and an average target price of $613.10.

Intuitive Surgical Price Performance

ISRG traded up $0.66 on Tuesday, hitting $574.14. 2,309,682 shares of the stock were exchanged, compared to its average volume of 2,014,252. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The firm has a market capitalization of $204.50 billion, a price-to-earnings ratio of 92.31, a PEG ratio of 5.19 and a beta of 1.39. The business has a 50-day moving average of $548.00 and a two-hundred day moving average of $506.12.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.